These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28853202)

  • 1. Ursodeoxycholic acid: Effects on hepatic unfolded protein response, apoptosis and oxidative stress in morbidly obese patients.
    Mueller M; Castro RE; Thorell A; Marschall HU; Auer N; Herac M; Rodrigues CMP; Trauner M
    Liver Int; 2018 Mar; 38(3):523-531. PubMed ID: 28853202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
    Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM
    J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic Acid (UDCA) Exerts Anti-Atherogenic Effects by Inhibiting Endoplasmic Reticulum (ER) Stress Induced by Disturbed Flow.
    Chung J; Kim KH; Lee SC; An SH; Kwon K
    Mol Cells; 2015 Oct; 38(10):851-8. PubMed ID: 26442866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity.
    Mueller M; Thorell A; Claudel T; Jha P; Koefeler H; Lackner C; Hoesel B; Fauler G; Stojakovic T; Einarsson C; Marschall HU; Trauner M
    J Hepatol; 2015 Jun; 62(6):1398-404. PubMed ID: 25617503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholic acid alleviates nonalcoholic fatty liver disease by inhibiting apoptosis and improving autophagy via activating AMPK.
    Wu P; Zhao J; Guo Y; Yu Y; Wu X; Xiao H
    Biochem Biophys Res Commun; 2020 Aug; 529(3):834-838. PubMed ID: 32595039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tunicamycin-Induced ER Stress is Accompanied with Oxidative Stress via Abrogation of Sulfur Amino Acids Metabolism in the Liver.
    Kim SH; Kwon DY; Kwak JH; Lee S; Lee YH; Yun J; Son TG; Jung YS
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30567393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effects of curcumin and ursodexycholic acid on non-alcoholic fatty liver disease.
    Gheibi S; Gouvarchin Ghaleh HE; Motlagh BM; Azarbayjani AF; Zarei L
    Biomed Pharmacother; 2019 Jul; 115():108938. PubMed ID: 31071511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway.
    Hu J; Hong W; Yao KN; Zhu XH; Chen ZY; Ye L
    World J Gastroenterol; 2019 Mar; 25(12):1492-1501. PubMed ID: 30948912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 78-kD Glucose-Regulated Protein Regulates Endoplasmic Reticulum Homeostasis and Distal Epithelial Cell Survival during Lung Development.
    Flodby P; Li C; Liu Y; Wang H; Marconett CN; Laird-Offringa IA; Minoo P; Lee AS; Zhou B
    Am J Respir Cell Mol Biol; 2016 Jul; 55(1):135-49. PubMed ID: 26816051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bicyclol attenuates tetracycline-induced fatty liver associated with inhibition of hepatic ER stress and apoptosis in mice.
    Yao XM; Li Y; Li HW; Cheng XY; Lin AB; Qu JG
    Can J Physiol Pharmacol; 2016 Jan; 94(1):1-8. PubMed ID: 26640164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-3 Polyunsaturated Fatty Acid: A Pharmaco-Nutraceutical Approach to Improve the Responsiveness to Ursodeoxycholic Acid.
    Thérien A; Cieślak A; Verreault M; Perreault M; Trottier J; Gobeil S; Vohl MC; Barbier O
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ipragliflozin Ameliorates Endoplasmic Reticulum Stress and Apoptosis through Preventing Ectopic Lipid Deposition in Renal Tubules.
    Hosokawa K; Takata T; Sugihara T; Matono T; Koda M; Kanda T; Taniguchi S; Ida A; Mae Y; Yamamoto M; Iyama T; Fukuda S; Isomoto H
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31888083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice.
    Tsuchida T; Shiraishi M; Ohta T; Sakai K; Ishii S
    Metabolism; 2012 Jul; 61(7):944-53. PubMed ID: 22154323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress mediated Ca(2+) release manifests endoplasmic reticulum stress leading to unfolded protein response in UV-B irradiated human skin cells.
    Farrukh MR; Nissar UA; Afnan Q; Rafiq RA; Sharma L; Amin S; Kaiser P; Sharma PR; Tasduq SA
    J Dermatol Sci; 2014 Jul; 75(1):24-35. PubMed ID: 24794973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenofibrate treatment attenuated chronic endoplasmic reticulum stress in the liver of nonalcoholic fatty liver disease mice.
    Zhang N; Lu Y; Shen X; Bao Y; Cheng J; Chen L; Li B; Zhang Q
    Pharmacology; 2015; 95(3-4):173-80. PubMed ID: 25896720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3 polyunsaturated fatty acid and ursodeoxycholic acid have an additive effect in attenuating diet-induced nonalcoholic steatohepatitis in mice.
    Kim JK; Lee KS; Lee DK; Lee SY; Chang HY; Choi J; Lee JI
    Exp Mol Med; 2014 Dec; 46(12):e127. PubMed ID: 25523099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced endoplasmic reticulum SERCA activity by overexpression of hepatic stimulator substance gene prevents hepatic cells from ER stress-induced apoptosis.
    Zhang J; Li Y; Jiang S; Yu H; An W
    Am J Physiol Cell Physiol; 2014 Feb; 306(3):C279-90. PubMed ID: 24284796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways.
    Weiss TS; Lupke M; Ibrahim S; Buechler C; Lorenz J; Ruemmele P; Hofmann U; Melter M; Dayoub R
    PLoS One; 2017; 12(9):e0184282. PubMed ID: 28877220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease.
    Nadinskaia M; Maevskaya M; Ivashkin V; Kodzoeva K; Pirogova I; Chesnokov E; Nersesov A; Kaibullayeva J; Konysbekova A; Raissova A; Khamrabaeva F; Zueva E
    World J Gastroenterol; 2021 Mar; 27(10):959-975. PubMed ID: 33776366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the Unfolded Protein Response by Tauroursodeoxycholic Acid Counteracts Apoptotic Cell Death and Fibrosis in a Mouse Model for Secondary Biliary Liver Fibrosis.
    Paridaens A; Raevens S; Devisscher L; Bogaerts E; Verhelst X; Hoorens A; Van Vlierberghe H; van Grunsven LA; Geerts A; Colle I
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.